SILVERARC CAPITAL MANAGEMENT, LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1816307
BOSTON, MA
Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,581,514
+$7,968,694 QoQ
Shares Held
311,461
+1.8% QoQ
Ownership
0.452%
of shares outstanding
% of Portfolio
3.85%
of 13F equity value
Holder Rank
#50
of 299 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. RYTM ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in RYTM
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,581,514 | 311,461 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $26,612,820 | 306,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,552,088 | 135,950 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $37,365,896 | 369,996 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,324,782 | 400,772 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,882,936 | 337,605 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,332,698 | 273,896 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,389,731 | 255,578 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,582,221 | 184,662 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,963,014 | 183,776 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,010,180 | 174,248 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,972,810 | 260,537 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,915,610 | 116,168 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||